Literature DB >> 3430480

Complement component deposition in uteroplacental (spiral) arteries in normal human pregnancy.

M Wells1, J Bennett, J N Bulmer, P Jackson, C S Holgate.   

Abstract

There is conflicting evidence for the deposition of complement in spiral arteries in normal and abnormal human pregnancies. The immunogold silver staining (IGSS) technique was used to investigate the distribution of C1q, C3d, C4, C6 and C9 within the spiral arteries of formalin-fixed normal pregnancy hysterectomy specimens ranging in gestational age from 4 to 40 weeks. Deposition of complement components studied was observed in all cases suggesting classical pathway activation. Reactivity was not confined to vessels showing endovascular trophoblast though the latter showed a characteristic linear deposition subjacent to the trophoblast. Reactivity was most intense for C3d and C9. An appreciation of complement deposition as a feature of normal pregnancy is essential before significant immunopathology can be recognised in placental bed vessels in abnormal pregnancy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3430480     DOI: 10.1016/0165-0378(87)90040-4

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  14 in total

Review 1.  Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.

Authors:  J E Salmon; G Girardi; V M Holers
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.

Authors:  Roberta Bulla; Chiara Agostinis; Fleur Bossi; Lucia Rizzi; Alessandra Debeus; Claudio Tripodo; Oriano Radillo; Francesco De Seta; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

Review 3.  Subinvolution of placental bed vessels: case report and review of the literature.

Authors:  Rajko Kavalar; Darja Arko; Nina Fokter Dovnik; Iztok Takač
Journal:  Wien Klin Wochenschr       Date:  2012-08-01       Impact factor: 1.704

4.  Polymorphisms in complement genes and risk of preeclampsia in Taiyuan, China.

Authors:  Weiwei Wu; Hailan Yang; Yongliang Feng; Ping Zhang; Shuzhen Li; Xin Wang; Tingting Peng; Fang Wang; Bingjie Xie; Pengge Guo; Mei Li; Ying Wang; Nan Zhao; Dennis Wang; Suping Wang; Yawei Zhang
Journal:  Inflamm Res       Date:  2016-07-12       Impact factor: 4.575

Review 5.  Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.

Authors:  A M Lynch; J E Salmon
Journal:  Placenta       Date:  2010-04-27       Impact factor: 3.481

6.  Mitigating placental injuries through up-regulating DAF in experimental APS mice: new mechanism of progesterone.

Authors:  Y Zhang; S Jin
Journal:  Clin Exp Immunol       Date:  2019-06-20       Impact factor: 4.330

Review 7.  The complement system and adverse pregnancy outcomes.

Authors:  Jean F Regal; Jeffrey S Gilbert; Richard M Burwick
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

8.  Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae.

Authors:  F Tedesco; O Radillo; G Candussi; A Nazzaro; T E Mollnes; D Pecorari
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

9.  Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Authors:  Mimi Y Kim; Marta M Guerra; Elianna Kaplowitz; Carl A Laskin; Michelle Petri; D Ware Branch; Michael D Lockshin; Lisa R Sammaritano; Joan T Merrill; T Flint Porter; Allen Sawitzke; Anne M Lynch; Jill P Buyon; Jane E Salmon
Journal:  Ann Rheum Dis       Date:  2018-01-25       Impact factor: 19.103

10.  Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation.

Authors:  Jane E Salmon; Guillermina Girardi
Journal:  Trans Am Clin Climatol Assoc       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.